We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tern Plc | LSE:TERN | London | Ordinary Share | GB00BFPMV798 | ORD 0.02P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 8.62% | 3.15 | 3.00 | 3.30 | 3.35 | 2.90 | 2.90 | 3,197,617 | 12:23:34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 66k | -10.45M | -0.0269 | -1.17 | 12.24M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/4/2024 08:10 | Get it sold | kkrriiss2 | |
16/4/2024 08:08 | Sellers building up strength | emigna2020 | |
16/4/2024 08:02 | BIG VOLUME DAY today. BIG BUYS. | steveberyl | |
16/4/2024 07:45 | Hundreds of $bn’s worldwide. And TM is in demand from big pharma agencies, which is nice. | still waiting | |
16/4/2024 07:26 | Yeah it will aid big pharma, but it's also going to help with drug wastage which currently runs into the hundreds of millions a year and, in the case of the UK at least therefore, is a sigjificant drain on NHS resources. So, not all bad;) | onsideman | |
16/4/2024 07:25 | You're too honest for today's world! 🤔 | juliemara | |
15/4/2024 22:11 | That techround article is inaccurate. Talking Medicines Drug-gpt is for use in better targeting of marketing.DRUGgpt is from Oxford University and is used to help optimise the prescribing of medicines.2 different but very similarly named tools from 2 separate organisations. | ricardox | |
15/4/2024 21:03 | "Drug-GPT" | stentorian | |
15/4/2024 20:00 | ChatGPT I think is generic. Drug GPT is what we're banking on. | ohsod1t | |
15/4/2024 19:48 | Is ChatGPT ahead of the game ? Questioned on any relationship between Device Authority and Thales, it responded :- "Device Authority is a provider of identity and access management solutions for the Internet of Things (IoT), focusing on securing connected devices and data. By acquiring Device Authority, Thales expanded its portfolio of digital identity and security solutions, particularly in the IoT sector. This acquisition allowed Thales to enhance its capabilities in providing secure authentication, data protection, and access control for IoT devices and ecosystems." Or, more likely, is ChatGPT fallible ? | mudbath | |
15/4/2024 18:42 | So a Wyld tease today !! They never tease, I wonder if Senet, MMC and global containers etc are finally about to go live. A refresh for any newbies | still waiting | |
15/4/2024 17:20 | A bit more placing stock gone, could be the lot.... | wardy333 | |
15/4/2024 16:45 | A nice start to the week. | bingoprize | |
15/4/2024 15:45 | Bidding War? for anything at Tern ? Apple v Meta ? Are you being serious? Why would anybody enter a BIDDING WAR when Tern can be approached to sell an interested party their holding in any Investee for BIG MONEY? Then approach investee. I assume the first signs of interest will be `CONSTANT BUYING` of Tern So many ways this whole saga ends. Certainly not in a BIDDING WAR. | steveberyl | |
15/4/2024 15:09 | New DA blog, dated today: | andrbea | |
15/4/2024 14:38 | I'm on an Oceania cruise. A chap onboard that was high up in the NHS had a look at TM for me. He said it has the chance to be very good as long as the security is completely tight. That is the main concern in this area. | ohsod1t | |
15/4/2024 14:16 | Quote today, from another player: In a security landscape where you must fight AI with AI, the best AI protection comes from having the best data. Zscaler has extended its Zero Trust architecture with powerful AI engines that are trained and tuned by 500 trillion daily signals. | andrbea |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions